Enterprise Value
$163.85 M
+$10.08 M+6.55%
Thu, 06 Feb 2025 23:34:21 GMT
Summary
- As of February 7, 2025, IKT enterprise value is $163.85 million, with a rise of +$10.08 million (+6.55%) during the most recent trading day.
- Over the past year, IKT enterprise value has increased by +$153.60 million (+1498.18%).
- IKT enterprise value is now -39.15% below its all-time high of $269.29 million.
Performance
IKT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
IKT Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +6.5% | +6.5% | +6.5% |
| 1 m1 month | -26.1% | -26.0% | -26.0% |
| 3 m3 months | -9.3% | -9.3% | -9.3% |
| 6 m6 months | +2285.3% | +1583.6% | +87.0% |
| ytdytd | -24.7% | -24.6% | -24.6% |
| 1 y1 year | +1498.2% | +758.4% | -21.0% |
| 5 y5 years | - | - | - |
IKT Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -26.1% | $138 M | +19.0% | |
| 3 m | 3-month | $269 M | -39.1% | $132 M | +24.5% |
| 6 m | 6-month | $269 M | -39.1% | $5.68 M | +2787.3% |
| 1 y | 1-year | $269 M | -39.1% | $3.57 M | +4487.2% |
| 3 y | 3-year | $269 M | -39.1% | -$21 M | +890.9% |
| 5 y | 5-year | $269 M | -39.1% | -$21 M | +890.9% |
| alltime | all time | $269 M | -39.1% | -$21 M | +890.9% |
Inhibikase Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $163.85 M(-24.7%) |
| 2024 | $217.61 M(<-9900.0%) |
| 2023 | -$1.25 M(-121.7%) |
| Date | Value |
|---|---|
| 2022 | $5.78 M(-263.9%) |
| 2021 | -$3.52 M(-106.3%) |
| 2020 | $55.71 M |
FAQ
- What is Inhibikase Therapeutics enterprise value?
- What is the all time high enterprise value for Inhibikase Therapeutics?
- What is IKT enterprise value year-to-date change?
- What is Inhibikase Therapeutics enterprise value year-on-year change?
What is Inhibikase Therapeutics enterprise value?
The current enterprise value of IKT is $163.85 M
What is the all time high enterprise value for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high enterprise value is $269.29 M
What is IKT enterprise value year-to-date change?
Inhibikase Therapeutics enterprise value has changed by -$53.75 M (-24.70%) since the beginning of the year
What is Inhibikase Therapeutics enterprise value year-on-year change?
Over the past year, IKT enterprise value has changed by +$153.60 M (+1498.18%)